IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer

NCT07692750 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: IBI343+ capecitabine
DRUG: IBI343+Capecitabine+oxaliplatin

Sponsor

Zhejiang Cancer Hospital